Efficacy and Safety of SR1375 in Adult Patients With CAP

NCT06577558 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Community-acquired Pneumonia

Interventions

DRUG: SR1375 capsule 3mg+regular treatments
DRUG: SR1375 capsule 1mg+regular treatments
DRUG: SR1375 capsule 0.3mg+regular treatments
DRUG: Placebo capsule+regular treatments

Sponsor

Shanghai SIMR Biotechnology Co., Ltd.